Two Words in a Results Letter Tell Patients the Opposite of What You Mean

Positive and negative are clear to a radiologist and backwards to the woman reading them at her kitchen table. Here is what the research shows, and the plain words that work better in the patient summary.

RD

Richard D. Lippert Jr.

President & Founder, Mammologix · Breast Imaging Operations since 1995

June 7, 20264 min read
Two words breast imaging results letters reach for first — positive and negative — mean the opposite to most patients of what they mean clinically. Here is what the evidence shows and what plain language looks like instead.
Share

MammoCommunicate · Patient Communication · Richard D. Lippert Jr., President & Founder, Mammologix · Breast Imaging Operations since 1995

Positive and negative are clear to a radiologist and backwards to the woman reading them at her kitchen table. Here is what the research shows, and the plain words that work better in the patient summary.


Picture the moment a woman opens the letter from the imaging center and reads that her mammogram was negative. Her stomach drops. Negative. She keeps reading and learns that negative is the good word here: nothing of concern, come back next year. The fear was real, and one word caused it, a word that means one thing in a report and close to the opposite at a kitchen table. The scene is a composite, but anyone who has fielded the follow-up phone calls has heard it.

Two words can cause a surprising amount of avoidable confusion, and they're the two a results letter reaches for first: positive and negative. They're precise, they're standard, and in a note meant for a patient they're among the riskiest words available.

What the research shows

Federal rules already take the patient's side here. Since September 2024, the amended Mammography Quality Standards Act has required every facility to send each patient a lay summary of her results written in terms a non-specialist can understand.1 The rule says the summary must be plain. It doesn't say which plain words work. That part is where the research comes in.

The clearest evidence doesn't come from breast imaging. It comes from a randomized trial in Germany that tested how ordinary people read test results. More than eleven hundred adults, matched by the country's age, gender, and education, each read the same result written in one of two ways. When it was framed as positive versus negative, 54 percent of readers without a medical background understood it correctly. When the same result was written as abnormal versus normal, 65 percent did. Same finding, different adjectives, and eleven more readers in every hundred got it right.2 The trial used a breath-test scenario, not a mammogram, so the numbers shouldn't be read as a measurement of breast imaging letters. The direction is the useful part: neutral, descriptive words land better than words that carry a judgment in everyday speech.

The reason these two words fail is that they flip what they mean in ordinary life. Outside a clinic, positive is the good column and negative is the bad one. A positive attitude, a negative review. Inside testing the logic reverses: a positive result found the thing being looked for, and a negative result didn't. For a cancer screen, that makes negative the result a patient wants and positive is the one that calls for a closer look. The letter is asking the reader to hold two opposite meanings in mind and pick the medical one under stress. Many don't.

Patients say so in their own words. In a study of how people read results in online portals, one man described opening an HIV result that read reactive and nonreactive instead of the plain negative he expected — and not knowing what he was looking at.3 The problem is common enough that a 2023 review of these barriers was titled, plainly, When Positive Is Negative.4

What to write instead

The fix has a real limit, and it matters. It does not mean stripping required terminology out of the official report. The amended MQSA still requires that report to carry the final assessment in fixed categories, and Negative is one of them. The American College of Radiology recommends the report show both the word and the category, such as BI-RADS® Category 1, Negative.5 That language belongs in the report to the referring provider. The patient's lay summary is a different document with a different job.

In the lay summary, the move is to lead with the plain meaning. Instead of telling a patient her mammogram was negative, the letter can say it looked normal and that no signs of cancer were seen. If a required term must appear, it reads better after the plain explanation, with the term defined rather than left to be decoded. A result that needs follow-up deserves the same care: the radiologist saw something that needs another look, more pictures are needed, and this is common and usually not cancer. ACR's own sample lay letters, revised in 2024, take this approach and pair any abnormal summary with a clear next step.5 The descriptive version says what happened and what to do in the same breath, so the reader doesn't have to translate.

This isn't about dumbing down a result. Swapping one clinical word for another wouldn't help much, because abnormal on its own can frighten a patient as easily as positive does. The gain comes from plain description. Phrases like looked normal or more pictures are needed are honest, because they say what the image showed instead of scoring it good or bad — and they're the wording the research found people understand.

A low-cost patient-safety improvement

There's a quiet reason this matters more than it looks like it should. Most efforts to make breast imaging safer cost real money and take years: new equipment, new tracking systems, more staff. Rewriting a lay-summary template costs almost nothing and can be done this quarter. It's a low-cost patient-safety improvement, and it lives in a document the facility is already required to send, in the exact moment a patient is most anxious and least able to decode clinical shorthand. That's the moment to use words that land the first time.


Sources

  1. US Food and Drug Administration. Important information: final rule to amend the Mammography Quality Standards Act (MQSA). Enforcement effective September 10, 2024. fda.gov

  2. Auschra C, Müller J, Berthod O, Mazheika Y, Borusiak P. Communicating test results in a comprehensible manner: a randomized controlled trial of word usage in doctor-patient communication. Z Evid Fortbild Qual Gesundhwes. 2020;156–157:40–49. doi:10.1016/j.zefq.2020.07.007

  3. Zhang Z, Citardi D, Xing A, Luo X, Lu Y, He Z. Patient challenges and needs in comprehending laboratory test results: mixed methods study. J Med Internet Res. 2020;22(12):e18725. doi:10.2196/18725

  4. Lazaro G. When positive is negative: health literacy barriers to patient access to clinical laboratory test results. J Appl Lab Med. 2023;8(6):1133–1147. doi:10.1093/jalm/jfad045

  5. American College of Radiology. Mammography (sample) lay report letters. Revised September 2024. acr.org

patient communicationresults lettersplain languageMQSAlay lettershealth literacypatient safety

About the Author

Richard D. Lippert Jr.

President & Founder, Mammologix · Breast Imaging Operations since 1995

Founder of Mammologix, Richard D. Lippert Jr. has spent more than 30 years in breast imaging operations — from clinical practice and hospital radiology administration to building specialized service platforms for imaging centers nationwide. His work spans mammography tracking, lay communication, FDA/MQSA-related support, medical outcome audit, and the operational systems that help facilities stay compliant and keep patients from falling through the cracks.

Full credentials and background →

Disclaimer

The content, articles, calculators, tools, estimates, projections, derived data, reports, and other materials provided by Mammologix, LLC, powered by I/O Trak, Inc. (“Mammologix”) are provided for informational and educational purposes only.

The information and outputs provided by Mammologix are not intended to serve as, and should not be relied upon as, medical advice, diagnosis, treatment, clinical guidance, financial advice, investment advice, tax advice, legal advice, accounting advice, or any other professional advice.

Information provided by Mammologix may relate to breast health, mammography, imaging, screening, diagnostics, clinical outcomes, healthcare topics, financial calculations, estimates, projections, or other decision-support information. However, such information should not be used to make personal medical, clinical, financial, investment, business, insurance, legal, or other important decisions without consulting an appropriate qualified professional.

Always seek the advice of a licensed physician, radiologist, healthcare provider, financial advisor, accountant, attorney, or other qualified professional with any questions you may have about a medical condition, screening recommendation, imaging result, treatment option, financial matter, or other professional decision. Never disregard professional medical, financial, legal, or other advice, or delay seeking such advice, because of something you have read, calculated, or received through Mammologix.

Any calculators, formulas, estimates, projections, derived medical outcome data, financial calculations, or other tool-generated outputs are provided as estimates only. Results may be affected by user-entered information, assumptions, formula limitations, incomplete or inaccurate data, rounding, software errors, third-party data, changing medical guidelines, changing financial conditions, changes in law or regulation, or other factors. Mammologix does not represent, warrant, or guarantee that any calculation, output, article, estimate, projection, or derived data is accurate, complete, current, reliable, suitable, or appropriate for any particular purpose.

For medical or health-related content and calculators, Mammologix does not provide medical advice, diagnosis, treatment recommendations, diagnostic interpretation, or patient-specific clinical decision-making. Mammologix content and tools are not a substitute for an in-person evaluation, professional medical consultation, diagnostic interpretation, or individualized care from a licensed healthcare provider. In the event of a medical emergency, contact emergency services or a qualified healthcare provider immediately.

For financial, business, tax, investment, or accounting-related calculators or content, Mammologix does not provide financial, investment, tax, legal, accounting, or business advice. Any outputs are estimates only, and actual results may vary materially based on personal circumstances, market conditions, taxes, fees, interest rates, inflation, risk tolerance, regulatory changes, and other factors.

Use of Mammologix content, articles, calculators, tools, and outputs is at your own risk. You are solely responsible for reviewing, verifying, and interpreting any information or results provided and for obtaining appropriate professional advice before relying on or acting upon such information.

Mammologix assumes no liability for any injury, loss, claim, damage, or expense arising from or related to the use of, reliance on, or inability to use any Mammologix content, article, calculator, tool, estimate, projection, derived data, report, or website material. To the fullest extent permitted by law, Mammologix, its owners, officers, employees, contractors, affiliates, licensors, service providers, and agents disclaim all liability for any direct, indirect, incidental, consequential, special, exemplary, punitive, financial, medical, clinical, business, or other damages arising out of or relating to the use of Mammologix materials or outputs.

The information provided by Mammologix does not establish a doctor-patient, provider-patient, radiologist-patient, financial advisor-client, attorney-client, accountant-client, fiduciary, or other professional relationship.

AI Content Disclosure

Some Mammologix content, calculations, summaries, tools, or outputs may be created, edited, generated, or assisted by artificial intelligence tools or automated systems. While Mammologix may review content for accuracy and relevance, AI-assisted or automated materials may contain errors, omissions, inaccuracies, outdated information, or outputs that are incomplete or inappropriate for a particular user, patient, circumstance, or purpose.

Users should independently verify all AI-assisted content, calculator outputs, and automated results with appropriate qualified professionals before relying on them.

See how Mammologix puts this into practice

Real operational support for breast imaging centers.